Calendario de promoción Mainz Biomed N.V.
Horario avanzado
gráfico sencillo
Acerca de la empresa
Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.
| Выручка |
0.000281 |
| EBITDA |
-0.000683 |
| Число акций ао |
0.01624 млрд |
| P/S |
129.77 |
| P/BV |
11.78 |
| EV/EBITDA |
-3.24 |
| Цена ао |
1.01 |
| ISIN |
NL0015000LC2 |
| Сайт |
https://mainzbiomed.com
|
| Валюта |
usd |
| IPO date |
2021-11-05 |
| Sector |
Health Care |
| Industry |
Biotechnology |
| Валюта отчета |
usd |
| Cambio de precio por día: |
-7.96% (0.2564) |
| Cambio de precio por semana.: |
-4.45% (0.247) |
| Cambio de precio por mes: |
-29.34% (0.334) |
| Cambio de precio en 3 meses.: |
-50.52% (0.477) |
| Cambio de precio en seis meses: |
-76.16% (0.99) |
| Cambio de precio por año: |
-91.54% (2.79) |
| Cambio de precio desde principios de año.: |
-89.46% (2.24) |
|
|
Subestimación
| Nombre |
Significado |
Calificación |
| P/S |
21.77 |
1 |
| P/BV |
6 |
2 |
| P/E |
0 |
0 |
| EV/EBITDA |
-0.8043 |
0 |
| Total: |
|
3.75 |
|
Eficiencia
| Nombre |
Significado |
Calificación |
| ROA, % |
-170.65 |
0 |
| ROE, % |
-809.29 |
0 |
| Total: |
|
0 |
|
|
|
Dividendos
| Nombre |
Significado |
Calificación |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Total: |
|
0 |
|
Deber
| Nombre |
Significado |
Calificación |
| Debt/EBITDA |
-0.2536 |
10 |
| Total: |
|
10 |
|
Impulso de crecimiento
| Nombre |
Significado |
Calificación |
| Rentabilidad Revenue, % |
218.68 |
10 |
| Rentabilidad Ebitda, % |
3511.77 |
10 |
| Rentabilidad EPS, % |
1841.2 |
10 |
| Total: |
|
10 |
|
| Supervisor |
Título profesional |
Pago |
año de nacimiento |
| Mr. Guido Baechler |
CEO & Executive Director |
N/A |
1965 (59 años) |
| Mr. William J. Caragol |
Chief Financial Officer |
N/A |
1967 (57 años) |
| Dr. Frank Krieg-Schneider |
Chief Technology Officer |
N/A |
1962 (62 año) |
| Dr. Moritz Eidens Ph.D. |
Chief Science Officer & Executive Director |
N/A |
1984 (40 años) |
| Stefan Erlach |
Head of Human Resources |
N/A |
|
| Mr. Philipp Freese |
Chief Business Officer |
N/A |
1983 (41 año) |
| Dr. Christopher Von Torne P.M.P., Ph.D. |
Chief Operating Officer |
N/A |
1972 (52 año) |
